- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Point-of-care Infectious Disease Diagnostics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Point-of-care Infectious Disease Diagnostics market. Detailed analysis of key players, along with key growth strategies adopted by Point-of-care Infectious Disease Diagnostics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Trinity Biotech
MedMira
Sekisui Diagnostics
Alere
Chembio Diagnostic Systems
Thermo Fisher Scientific
OraSure Technologies
Calypte Biomedical
Quidel
Meridian Bioscience
By Type:
HIV POC
Clostridium Difficile POC
HBV POC
Respiratory Syncytial Virus POC
HPV POC
Influenza/Flu POC
HCV POC
MRSA POC
TB and Drug-Resistant TB POC
By End-User:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratories
Others
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Point-of-care Infectious Disease Diagnostics Market
-
1.3 Market Segment by Type
-
1.3.1 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HIV POC from 2016 to 2027
-
1.3.2 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clostridium Difficile POC from 2016 to 2027
-
1.3.3 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HBV POC from 2016 to 2027
-
1.3.4 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Respiratory Syncytial Virus POC from 2016 to 2027
-
1.3.5 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HPV POC from 2016 to 2027
-
1.3.6 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Influenza/Flu POC from 2016 to 2027
-
1.3.7 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HCV POC from 2016 to 2027
-
1.3.8 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of MRSA POC from 2016 to 2027
-
1.3.9 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of TB and Drug-Resistant TB POC from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.4.3 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Home from 2016 to 2027
-
1.4.4 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Assisted Living Healthcare Facilities from 2016 to 2027
-
1.4.5 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027
-
1.4.6 USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Point-of-care Infectious Disease Diagnostics Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Point-of-care Infectious Disease Diagnostics by Major Types
-
3.4.1 Market Size and Growth Rate of HIV POC
-
3.4.2 Market Size and Growth Rate of Clostridium Difficile POC
-
3.4.3 Market Size and Growth Rate of HBV POC
-
3.4.4 Market Size and Growth Rate of Respiratory Syncytial Virus POC
-
3.4.5 Market Size and Growth Rate of HPV POC
-
3.4.6 Market Size and Growth Rate of Influenza/Flu POC
-
3.4.7 Market Size and Growth Rate of HCV POC
-
3.4.8 Market Size and Growth Rate of MRSA POC
-
3.4.9 Market Size and Growth Rate of TB and Drug-Resistant TB POC
4 Segmentation of Point-of-care Infectious Disease Diagnostics Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Point-of-care Infectious Disease Diagnostics by Major End-Users
-
4.4.1 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Hospitals
-
4.4.2 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Clinics
-
4.4.3 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Home
-
4.4.4 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Assisted Living Healthcare Facilities
-
4.4.5 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Laboratories
-
4.4.6 Market Size and Growth Rate of Point-of-care Infectious Disease Diagnostics in Others
5 Market Analysis by Regions
-
5.1 USA Point-of-care Infectious Disease Diagnostics Production Analysis by Regions
-
5.2 USA Point-of-care Infectious Disease Diagnostics Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis
-
6.1 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types
-
6.2 West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users
7 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis
-
7.1 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types
-
7.2 South USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users
8 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis
-
8.1 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types
-
8.2 Middle West USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users
9 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis
-
9.1 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major Types
-
9.2 Northeast USA Point-of-care Infectious Disease Diagnostics Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Trinity Biotech
-
10.1.1 Trinity Biotech Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 MedMira
-
10.2.1 MedMira Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Sekisui Diagnostics
-
10.3.1 Sekisui Diagnostics Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Alere
-
10.4.1 Alere Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Chembio Diagnostic Systems
-
10.5.1 Chembio Diagnostic Systems Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Thermo Fisher Scientific
-
10.6.1 Thermo Fisher Scientific Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 OraSure Technologies
-
10.7.1 OraSure Technologies Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Calypte Biomedical
-
10.8.1 Calypte Biomedical Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Quidel
-
10.9.1 Quidel Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 Meridian Bioscience
-
10.10.1 Meridian Bioscience Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HIV POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clostridium Difficile POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HBV POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Respiratory Syncytial Virus POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HPV POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Influenza/Flu POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of HCV POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of MRSA POC from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of TB and Drug-Resistant TB POC from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Home from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Assisted Living Healthcare Facilities from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Laboratories from 2016 to 2027
-
Figure USA Point-of-care Infectious Disease Diagnostics Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Point-of-care Infectious Disease Diagnostics Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Point-of-care Infectious Disease Diagnostics
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Point-of-care Infectious Disease Diagnostics by Different Types from 2016 to 2027
-
Table Consumption Share of Point-of-care Infectious Disease Diagnostics by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of HIV POC
-
Figure Market Size and Growth Rate of Clostridium Difficile POC
-
Figure Market Size and Growth Rate of HBV POC
-
Figure Market Size and Growth Rate of Respiratory Syncytial Virus POC
-
Figure Market Size and Growth Rate of HPV POC
-
Figure Market Size and Growth Rate of Influenza/Flu POC
-
Figure Market Size and Growth Rate of HCV POC
-
Figure Market Size and Growth Rate of MRSA POC
-
Figure Market Size and Growth Rate of TB and Drug-Resistant TB POC
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Point-of-care Infectious Disease Diagnostics by Different End-Users from 2016 to 2027
-
Table Consumption Share of Point-of-care Infectious Disease Diagnostics by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Figure Market Size and Growth Rate of Home
-
Figure Market Size and Growth Rate of Assisted Living Healthcare Facilities
-
Figure Market Size and Growth Rate of Laboratories
-
Figure Market Size and Growth Rate of Others
-
Table USA Point-of-care Infectious Disease Diagnostics Production by Regions
-
Table USA Point-of-care Infectious Disease Diagnostics Production Share by Regions
-
Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2016
-
Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2021
-
Figure USA Point-of-care Infectious Disease Diagnostics Production Share by Regions in 2027
-
Table USA Point-of-care Infectious Disease Diagnostics Consumption by Regions
-
Table USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions
-
Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2016
-
Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2021
-
Figure USA Point-of-care Infectious Disease Diagnostics Consumption Share by Regions in 2027
-
Table West USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027
-
Table West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027
-
Table West USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027
-
Table West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021
-
Figure West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027
-
Table South USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027
-
Table South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027
-
Table South USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027
-
Table South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021
-
Figure South USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027
-
Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027
-
Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027
-
Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021
-
Figure Middle West USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027
-
Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption by Types from 2016 to 2027
-
Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2016
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2021
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by Types in 2027
-
Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2016
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2021
-
Figure Northeast USA Point-of-care Infectious Disease Diagnostics Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Trinity Biotech
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Trinity Biotech
-
Figure Sales and Growth Rate Analysis of Trinity Biotech
-
Figure Revenue and Market Share Analysis of Trinity Biotech
-
Table Product and Service Introduction of Trinity Biotech
-
Table Company Profile and Development Status of MedMira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of MedMira
-
Figure Sales and Growth Rate Analysis of MedMira
-
Figure Revenue and Market Share Analysis of MedMira
-
Table Product and Service Introduction of MedMira
-
Table Company Profile and Development Status of Sekisui Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sekisui Diagnostics
-
Figure Sales and Growth Rate Analysis of Sekisui Diagnostics
-
Figure Revenue and Market Share Analysis of Sekisui Diagnostics
-
Table Product and Service Introduction of Sekisui Diagnostics
-
Table Company Profile and Development Status of Alere
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Alere
-
Figure Sales and Growth Rate Analysis of Alere
-
Figure Revenue and Market Share Analysis of Alere
-
Table Product and Service Introduction of Alere
-
Table Company Profile and Development Status of Chembio Diagnostic Systems
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Chembio Diagnostic Systems
-
Figure Sales and Growth Rate Analysis of Chembio Diagnostic Systems
-
Figure Revenue and Market Share Analysis of Chembio Diagnostic Systems
-
Table Product and Service Introduction of Chembio Diagnostic Systems
-
Table Company Profile and Development Status of Thermo Fisher Scientific
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Thermo Fisher Scientific
-
Figure Sales and Growth Rate Analysis of Thermo Fisher Scientific
-
Figure Revenue and Market Share Analysis of Thermo Fisher Scientific
-
Table Product and Service Introduction of Thermo Fisher Scientific
-
Table Company Profile and Development Status of OraSure Technologies
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OraSure Technologies
-
Figure Sales and Growth Rate Analysis of OraSure Technologies
-
Figure Revenue and Market Share Analysis of OraSure Technologies
-
Table Product and Service Introduction of OraSure Technologies
-
Table Company Profile and Development Status of Calypte Biomedical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Calypte Biomedical
-
Figure Sales and Growth Rate Analysis of Calypte Biomedical
-
Figure Revenue and Market Share Analysis of Calypte Biomedical
-
Table Product and Service Introduction of Calypte Biomedical
-
Table Company Profile and Development Status of Quidel
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Quidel
-
Figure Sales and Growth Rate Analysis of Quidel
-
Figure Revenue and Market Share Analysis of Quidel
-
Table Product and Service Introduction of Quidel
-
Table Company Profile and Development Status of Meridian Bioscience
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Meridian Bioscience
-
Figure Sales and Growth Rate Analysis of Meridian Bioscience
-
Figure Revenue and Market Share Analysis of Meridian Bioscience
-
Table Product and Service Introduction of Meridian Bioscience
-

Chinese